QuickView for aldo-keto reductase (NADP) activity (biogroup)

1. L1000 CMAP - Breast cancer MCF7.311 cells with CRISPR-induced gene knockouts
2. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
3. L1000 CMAP - Neuronal NEU cells treated with small molecule perturbagens
4. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
5. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens

1. Comparative proteomic study between tuberous roots of light orange- and purple-fleshed sweetpotato c…
2. Genomic alterations in breast cancer patients in betel quid and non betel quid chewers.
3. Effect of cytochrome P450 and aldo-keto reductase inhibitors on progesterone inactivation in primary…
4. A chimeric fusion protein engineered with disparate functionalities-enzymatic activity and self-asse…
5. Crystallization and aldo-keto reductase activity of Gcy1p from Saccharomyces cerevisiae.

There were no clinical trials for aldo-keto reductase (NADP) activity